Skip to main content
. 2020 Aug 20;12(9):915. doi: 10.3390/v12090915

Table 1.

Study cohort. Age, sex and ethnicity of rVSV-ZEBOV vaccinees at d0 and of EVD survivors on day of blood sampling are shown. Absolute numbers (%) are displayed unless otherwise specified.

rVSV-ZEBOV Vaccinees
(n = 10)
EVD Survivors
(n = 25)
Age, mean (SD) (y) 40.4 (8.7) 32.0 (12.9)
median (range) (y) 40 (24–52) 31 (18–58)
Sex
female 3 (30%) 11 (44%)
male 7 (70%) 14 (56%)
Ethnicity
white 10 (100%) 0
Black or African American 0 10 (100%)